ALSO READGufic Biosciences to merge Gufic Stridden Bio-Pharma with self Gufic Biosciences appoints additional independent director Gufic Biosciences gets assigned ratings for bank facilities Gufic BioSciences standalone net profit rises 145.19% in the June 2016 quarter Gufic BioSciences standalone net profit rises 60.00% in the September 2016 quarter
With effect from 14 November 2016Gufic Biosciences announced that the Board of Directors of the Company at its meeting held on 14 November 2016, inter alia, has accepted the resignation of Ashok M. Tarale as an Independent Director of the Company w.e.f. 14 November 2016.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)